Delivery Order 75N95022D00017-75N95023F00012
Award Date
9/15/23
Potential Completion Date
4/28/25
Potential Value
$755K
Federal Agency
National Institute on Drug Abuse
Awardee
The Emmes Company LLC
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost Plus Fixed Fee
Place of Performance
Potomac, MD 20850, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Service Contract Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $799,919.00 cost-plus-fixed-fee delivery order contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to The Emmes Company LLC, a for-profit limited liability company. The contract supports the NIDA Data, Statistics, and Clinical Trial Support Center and covers a period from September 15, 2023 to March 31, 2025, with a final completion date of April 28, 2025. The contract is not set-aside. Emmes, a global clinical research organization, will provide...
This is a $1,406,983.00 cost-plus-fixed-fee delivery order contract awarded to The Emmes Company LLC by the National Institute on Drug Abuse (NIDA), a civilian agency, to provide data, statistics, and clinical trial support center management and support services. The work is being performed under Task Order 75N95021F00004 (TO23) of NIDA's $31.2 million Data, Statistics, and Clinical Trial Support Center Management and Support indefinite delivery contract, awarded without a set-aside designation....
This is a delivery order awarded to The Emmes Company LLC by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute on Drug Abuse (NIDA). The $622,266 contract, issued under NIDA's $31.2 million Data, Statistics, and Clinical Trial Support Center indefinite delivery contract, funds an Exemplar Hospital Initiation Trial to Enhance Treatment Engagement (CTN-0098) from June 2024 to November 2026. As a global clinical research organization, The Emmes...
The Emmes Company LLC was awarded a cost-plus-fixed-fee delivery order valued at approximately $958,000 by the Department of Health and Human Services' National Institutes of Health National Institute on Drug Abuse to provide data, statistics, and clinical trial support services under the NIDA DATA, STATISTICS, AND CLINICAL TRIAL SUPPORT CENTER contract vehicle. Performance will take place in Potomac, Maryland from September 2019 through February 2020. No set-aside designation was specified. The...
This is a Cost Plus Fixed Fee delivery order awarded by the National Institute on Drug Abuse (NIDA), a civilian agency within the National Institutes of Health (NIH), to The Emmes Company LLC, a for-profit limited liability company based in Rockville, Maryland. The contract is for a project titled "PHARMACIST-INTEGRATED MODEL OF MEDICATION TREATMENT FOR OPIOID USE DISORDER" with a period of performance from December 1, 2023 to March 31, 2025. The contract has a ceiling value of...
The Emmes Company LLC was awarded a cost plus fixed fee delivery order valued at approximately $1.1 million by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health within the Department of Health and Human Services. The order is being issued against the NIDA DATA, STATISTICS, AND CLINICAL TRIAL SUPPORT CENTER management and support contract vehicle to provide management and support services for the Center from March 2021 through February 2022. Performance...
This is a $28,504,143.19 federal contract awarded to The Emmes Company LLC, a for-profit limited liability company, by the National Institute on Drug Abuse (NIDA), a civilian agency under the National Institutes of Health (NIH). The contract, titled "DATA, STATISTICS, AND CLINICAL TRIAL SUPPORT FOR NIDA (DSC4)", is a 5-year cost-plus-fixed-fee definitive contract with a period of performance from June 19, 2014 to June 18, 2019. The contract was set aside for small businesses. The Emmes...
This is a cost-plus-fixed-fee delivery order contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to The Emmes Company LLC, a for-profit limited liability company, to provide clinical coordinating center support services. The contract has a ceiling value of $3,744,211.88 and a period of performance from August 14, 2020 to August 13, 2021. The contract is not set aside for any specific business type. The Emmes Company LLC is a global clinical research organization...
This is a $5,989,270.00 cost-plus-fixed-fee delivery order to The Emmes Company LLC, a global clinical research organization, to serve as the Clinical Coordinating Center for the National Institute on Drug Abuse's (NIDA) Clinical Trials Network. The order has a period of performance from May 15, 2023 to May 14, 2024 and was awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH). The Emmes Company, a for-profit limited liability company, will provide a...
This is a cost-plus-fixed-fee delivery order contract awarded by the National Institute on Drug Abuse (NIDA) to The Emmes Company LLC, a global clinical research organization. The contract supports the "Subthreshold Opioid Use Disorder Prevention Trial" (CTN-0101) for the period of August 1, 2024 to March 31, 2026. The total ceiling value of the contract is $113,621.00. This contract is not set aside for any specific business type. The Emmes Company LLC is an experienced provider of...